Table 1 Phenotypic features of myoglobinopathy

From: Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions

 

Family 1

Family 2

Family 3

Family 4

Family 5

Family 6

Inheritance pattern

AD

AD

AD

AD

unknown

unknown

Myoglobin mutation

His98Tyr

His98Tyr

His98Tyr

His98Tyr

His98Tyr

His98Tyr

Country of origin

Spain

Spain

Sweden

France

France

Netherlands

No. of patients

2

1

6

3

1

1

Mean age of onset (range)

37.5 (36–39)

38

44.5 (39–49)

46 (44–48)

40

33

Gender (female/male)

0/2

1/0

2/4

2/1

0/1

0/1

Initial symptoms

Proximal LL and axial weakness (2/2)

Proximal LL and axial weakness (1/1)

Distal hand weakness (2/6)

Proximal LL and axial weakness (6/6)

Proximal LL and axial weakness (3/3)

Proximal LL weakness (1/1)

Proximal LL and axial weakness (1/1)

Symptoms at advanced disease

 Distribution of weakness

Proximal and axial > distal 4 EE

Proximal and axial > distal 4 EE

Proximal and axial > distal 4 EE

Proximal and distal 4 EE > axial

Proximal and axial > distal 4 EE

Proximal and axial > distal legs

 Involvement of hand muscles

2/2

1/1

6/6

2/2**

1/1

0/1

 Facial weakness

0/2

0/1

0/6

0/2

0/1

0/1

 Muscle atrophy

2/2

1/1

6/6

2/2

0/1

1/1

 Dysphagia

2/2

0/1

2/4

0/2

1/1

0/1

 Respiratory insufficiency

2/2

1/1

2/6

1/2

1/1

1/1

 Cardiac involvement*

2/2

1/1

2/6

0/2

1/1

0/1

Clinical outcome

 Mean age at wheelchair dependency

54

65

56 (4/6 patients wheelchair dependent, 2/6 ambulant)

66 (1/3 patients wheelchair dependent, 2/3 ambulant)

56

47

 Mean age at death (range)

60.5 (54–67)

64 (58–71)

72

Laboratory studies

 CK fold elevation above normal levels

1.5–2

2

1.5–4

2.3–3.7

4

3.5–7

 EMG

Myogenic with spontaneous activity at rest

Myogenic with spontaneous activity at rest

Myogenic with spontaneous activity at rest

Myogenic with spontaneous activity at rest

Myogenic with spontaneous activity at rest

Myogenic with spontaneous activity at rest

  1. *As revealed by cardiac ultrasound, cardiac MRI, or by post mortem examination of cardiac muscle. ** Individual III:2 from Fam 4 is in the early stages of the disease and therefore not included in symptoms at advanced disease items. EE: extremities; LL: lower limbs